Literature DB >> 16301592

The epothilone dilemma.

Maja de Jonge, Jaap Verweij.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16301592     DOI： 10.1200/JCO.2005.03.8844

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Epothilones: From discovery to clinical trials.

Authors:  Stefano Forli
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

2.  Improved i.p. drug delivery with bioadhesive nanoparticles.

Authors:  Yang Deng; Fan Yang; Emiliano Cocco; Eric Song; Junwei Zhang; Jiajia Cui; Muneeb Mohideen; Stefania Bellone; Alessandro D Santin; W Mark Saltzman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

3.  Phase I trial and pharmacokinetic study of ixabepilone administered daily for 5 days in children and adolescents with refractory solid tumors.

Authors:  Brigitte C Widemann; Wendy Goodspeed; Anne Goodwin; Tito Fojo; Frank M Balis; Elizabeth Fox
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

4.  De(side chain) model of epothilone: bioconformer interconversions DFT study.

Authors:  Danuta Rusinska-Roszak; Marek Lozynski
Journal:  J Mol Model       Date:  2009-01-20       Impact factor: 1.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.